ETF PROAI

IBRNvsVSDA

iShares Neuroscience and Healthcare ETF against VICTORYSHARES DIVIDEND ACCELERATOR ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
IBRN 119VSDA 105Oct 25Oct 26GROWTH OF $100
Head to head
IBRNVSDA
Expense ratio0.47%—
Assets$6640.17T$262M
Net flow, 1 month+$94K—
Net flow, 1 year+$2M—
Return, YTD+0.7%+6.6%
Return, 1 year+18.6%+5.2%
Avg daily volume2K7K
Holdings5475
ListedAug 24, 2022Mar 3, 2024
Options marketYesYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.